Skip to main content
. 2017 Feb 8;6(2):e1273311. doi: 10.1080/2162402X.2016.1273311

Table 2.

Safety profiles after T-cell therapy.

Adverse events n = 30 (%)
Grade 1 10 (33.3%)
Fatigue 1 (3.3%)
Dry cough 1 (3.3%)
Fever 3 (10%)
Chills 1 (3.3%)
Chest pain 1 (3.3%)
Sore throat 1 (3.3%)
Hyperbilirubinemia 1 (3.3%)
Altered hearing ability 1 (3.3%)
Grade 2 6 (20%)
Fatigue 2 (6.7%)
Fever 1 (3.3%)
Dyspnea 1 (3.3%)
Headache 1 (3.3%)
Vomiting 1 (3.3%)
Grade 3 2 (6.7%)
Lung abscess 2 (6.7%)